We are now offering volume licensing for JMP Clinical 3.1 for $50 per computer.
JMP Clinical software from SAS shortens the drug development process by streamlining the exploration, review and submission of clinical trial data. With a visual, information-seeking approach that links advanced analytics with graphics, JMP Clinical offers the thorough and efficient exploration needed in a modern review environment. JMP Clinical uses globally recognized CDISC data to generate reports – including patient profiles and narratives – for submission to the US Food and Drug Administration. It combines JMP, already a popular tool of choice for medical reviewers, and SAS, the standard analysis and reporting tool for biostatisticians in the pharma industry.
The desktop software depicts analysis results visually, so you can spot trends that spreadsheets and static tables tend to hide. It permits clustering of events, interventions and findings and offers effortless access to the statistical details behind the graphics, a benefit not found in similar offerings.
JMP Clinical is designed for medical reviewers, medical writers, data monitors and biostatisticians engaged in analyzing safety data from clinical trials.
This will be an experimental program for 2012, and we will attempt to recover our costs by reselling individual licenses for $50 each (normally $1600). If we sell enough licenses to recover our costs, the program will be renewed for 2013, and the price will be lowered based on the number sold. We hope that you will spread the word about this program with your colleagues since it represents a very good value.
Licenses purchased today will expire on December 30, 2012.
